SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-21-023302
Filing Date
2021-10-05
Accepted
2021-10-05 17:01:27
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 dmtp20211001_s3.htm S-3 479403
2 EXHIBIT 4.5 ex_288747.htm EX-4.5 94483
3 EXHIBIT 5.1 ex_288748.htm EX-5.1 10436
4 EXHIBIT 23.1 ex_288749.htm EX-23.1 2430
5 dmtp20211001_s3img001.gif GRAPHIC 4557
6 i01.jpg GRAPHIC 24048
7 logolg.jpg GRAPHIC 7356
  Complete submission text file 0001437749-21-023302.txt   637719
Mailing Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-260066 | Film No.: 211307537
SIC: 2834 Pharmaceutical Preparations